Related Experiment Video
Updated: Apr 15, 2026

MicroRNA Amplification and Recognition through Locked-nucleic-acid In situ Hybridization as a Novel Detection and Quantification Method
Published on: October 7, 2025
MicroRNAs as the fine-tuners of Src oncogenic signalling
Chitose Oneyama1, Masato Okada2
1Division of Microbiology and Oncology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, Japan and Department of Oncogene Research, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan Division of Microbiology and Oncology, Aichi Cancer Center Research Institute, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi 464-8681, Japan and Department of Oncogene Research, Research Institute for Microbial Diseases, Osaka University, 3-1 Yamadaoka, Suita, Osaka 565-0871, Japan coneyama@aichi-cc.jp.
Abstract:
The cellular Src (c-Src) tyrosine kinase is upregulated and believed to play a pivotal role in various human cancers. However, the molecular mechanism underlying c-Src-mediated tumour progression remains elusive. Recent studies have revealed that several microRNAs (miRNAs) function as tumour suppressors by regulating the malignant expression of signalling molecules. Aberrant expression of miRNAs is frequently observed in human cancers and should be exploited to seek related molecular targets. In this review, we focus on miRNAs found to be involved in Src signalling in various cancers. We summarize recent findings on Src-related miRNAs, their target genes, mechanisms behind their interplay and their implications for cancer therapeutics.
Insights
MicroRNAs (miRNAs) regulate the signaling molecule Src, which is linked to cancer progression. Understanding these miRNA-Src interactions may reveal new therapeutic targets for human cancers.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Cellular Src (c-Src) tyrosine kinase is upregulated in various human cancers, but its precise role in tumor progression is unclear.
- MicroRNAs (miRNAs) are emerging as tumor suppressors that regulate signaling molecules, and their aberrant expression is common in cancer.
Purpose of the Study:
- To review the role of miRNAs in Src signaling pathways across different cancers.
- To elucidate the molecular mechanisms underlying miRNA-Src interactions and their therapeutic implications.
Main Methods:
- Literature review of recent studies on miRNAs involved in Src signaling.
- Analysis of miRNA target genes and their interplay with Src signaling pathways.
Main Results:
- Several miRNAs have been identified as regulators of Src signaling in cancer.
- These miRNAs target genes involved in crucial cancer-related pathways.
- The interplay between miRNAs and Src signaling offers potential therapeutic strategies.
Conclusions:
- miRNAs play a significant role in regulating Src signaling in human cancers.
- Targeting miRNA-Src interactions presents a promising avenue for novel cancer therapeutics.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
MicroRNAs
MicroRNAs
MicroRNAs
Abnormal Proliferation

